IGFBP7 and soft tissue sarcoma: For example, MS Benassi et al. (2015) reported that the expression of IGFBP7, considered a tumor stroma marker in mesenchymal-derived cells, was highly prognostic in poor metastasis-free survival for soft tissue sarcoma.